Paclitaxel-loaded lipid nanoparticles for topical application: the influence of oil content on lipid dynamic behavior, stability, and drug skin penetration

Journal of Nanoparticle Research

Volumn 16, Issue 12, 2014, Pages 1-12

  Tosta, Fabiana Vaz ^a   Andrade, Lígia Marquez ^a   Mendes, Lívia Palmerston ^a   Anjos, Jorge Luiz V ^a   Alonso, Antonio ^a   Marreto, Ricardo Neves ^a   Lima, Eliana Martins ^a   Taveira, Stephânia Fleury ^a  

^a FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

Author keywords

Lipid dynamic behavior and electron paramagnetic resonance spectroscopy; Nanostructured lipid carriers; Paclitaxel; Skin permeation; Solid lipid nanoparticles

Indexed keywords

CHEMICAL STABILITY; ELECTRON RESONANCE; ELECTRON SPIN RESONANCE SPECTROSCOPY; NANOPARTICLES; PARAMAGNETIC RESONANCE; PARAMAGNETISM;

ELECTRON PARAMAGNETIC RESONANCE SPECTROSCOPY; NANOSTRUCTURED LIPID CARRIERS; PACLITAXEL; SKIN PERMEATION; SOLID LIPID NANOPARTICLE (SLN);

DRUG DELIVERY;

PACLITAXEL; SOLID LIPID NANOPARTICLE;

ARTICLE; DRUG PENETRATION; DRUG RELEASE; DRUG STABILITY; ELECTRON SPIN RESONANCE; RIGIDITY; SKIN; SKIN PENETRATION; STORAGE; TOPICAL TREATMENT; ZETA POTENTIAL;

EID: 84920422840     PISSN: 13880764     EISSN: 1572896X     Source Type: Journal    
DOI: 10.1007/s11051-014-2782-7     Document Type: Article

References (34)

1. Amjadi I, Rabiee M, Hosseini MS, Mozafari M (2012) Synthesis and characterization of doxorubicin-loaded poly (lactide-co-glycolide) nanoparticles as sustained-release anticancer drug delivery system. Appl Biochem Biotechnol 168:1434–1447
2. Andrade LM, Reis CF, Maione-Silva L, Anjos JLV, Alonso A, Serpa RC, Marreto RN, Lima EM, Taveira SF (2014) Impact of lipid dynamic behavior on physical stability, in vitro release and skin permeation of genistein-loaded lipid nanoparticles. Eur J Pharm Biopharm. doi:10.1016/j.ejpb.2014.04.015
3. Budil DE, Lee S, Saxena S, Freed JH (1996) Nonlinear-least-square analysis of slow-motion EPR spectra in one and two dimensions using a modified Levenberg-Marquardt algorithm. J Megn Reson A 120:155–189
4. Contreras MJF, Soriano MMJ, Diéguez AR (2005) In vitro percutaneous absorption of all-trans retinoic acid applied in free form or encapsulated in stratum corneum lipid liposomes. Int J Pharm 297:134–145
5. Das S, Ng WK, Tan RBH (2012) Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs? Eur J Pharm Sci 47:139–151
6. Fang JY, Fang CL, Liu CH, Su YH (2008) Lipid nanoparticles as vehicles for topical psoralen delivery: solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC). Eur J Pharm Biopharm 70:633–640
7. FDA, Food and Drug Administration—Guidance for Industry (2001) Analytical procedures and methods validation: chemistry, manufacturing and controls documentation. Rockville: US Food and Drug Administration 33
8. Haag SF, Chen M, Peters D, Keck CM, Taskoparan B, Fahr A, Teuloff C, Bittl R, Lademann J, Schäfer-Korting M, Meinke MC (2011) Nanostructured lipid carriers as nitroxide depot system measured by electron paramagnetic resonance spectroscopy. Int J Pharm 421:364–369
9. Huang ZR, Hua SC, Yang YL, Fang JY (2008) Development and evaluation of lipid nanoparticles for camptothecin delivery: a comparison of solid lipid nanoparticles, nanostructured lipid carriers and lipid emulsion. Acta Pharmacol Sin 29:1094–1102
10. Jenning V, Thünemann AF, Gohla SH (2000) Characterization of a novel solid lipid nanoparticle carrier system based on binary mixtures of liquid and solid lipids. Int J Pharm 199:167–177
11. Jin C, Yang Z, Yang J, Li H, He Y, An J, Bai L, Dou K (2014) Paclitaxel-loaded nanoparticles decorated with anti-CD133 antibody: a target therapy for liver cancers stem cells. J Nanopart Res 16:1–15
12. Jores K, Mehnert W, Mäder K (2003) Physicochemical investigations on solid lipid nanoparticles and on oil-loaded solid lipid nanoparticles: a nuclear magnetic resonance and electron spin resonance study. Pharm Res 20:1274–1283
13. Kilfoyle BE, Sheihet L, Zhang Z, Laohoo M, Kohn J, Michniak-Kohn BB (2012) Development of paclitaxel-tyrospheres for topical skin treatment. J Control Release 163:18–24
14. Knox SN, Robinson JB, Im DD, Logan L, Rosenshein NB (2000) The use of paclitaxel and cisplatin in a patient with epithelial ovarian cancer and human immunodeficiency virus. Gynecol Oncol 76:118–122
15. Kovacevic A, Savic S, Vuleta G, Müller RH, Keck CM (2011) Polyhydroxy surfactants for the formulation of lipid nanoparticles (SLN and NLC): effect on size, physical stability and particle matrix structure. Int J Pharm 406:163–172
16. Lippacher A, Müller RH, Mäder K (2001) Preparation of semi-solid drug carriers for topical application based on solid lipid nanoparticles. Int J Pharm 124:9–12
17. Lopez RFV, Seto JE, Blankschtein D, Langer DR (2011) Enhancing the transdermal delivery of rigid nanoparticles using the simultaneous application of ultrasound and sodium lauryl sulfate. Biomaterials 32:933–941
18. Maione-Silva L, Rocha KADR, Oliveira LC, Taveira SF, Lima EM (2012) Development and validation of a simple and rapid lipid chromatography method for the determination of genistein in skin permeation studies. Biol Pharm Bull 35:1986–1990
19. Mendanha SA, Moura SS, Anjos JLV, Valadares MC, Alonso A (2013) Toxicity of terpenes on fibroblast cells compared to their hemolytic potential and increase in erythrocyte membrane fluidity. Toxicol In Vitro 27:323–329
20. Michniak BB, Player MR, Chapman JM Jr, Sowell JW Sr (1994) Azone analogues as penetration enhancers: effect of different vehicles on hydrocortisone acetate skin permeation and retention. J Control Release 32:147–154
21. Müller RH, Radtke M, Wissing SA (2002) Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv Drug Deliv Rev 54:S131–S155
22. Müller RH, Petersen RD, Hommoss A, Pardeike J (2007) Nanostructured lipid carriers (NLC) in cosmetic dermal products. Adv Drug Deliv Rev 59:522–530
23. ®: potential treatment of squamous cell carcinoma, a malignant transformation of actinic keratoses. Eur J Pharm Biopharm 81:102–112
24. Prow TW, Grice JE, Lin LL, Faye R, Butler M, Becker W, Wurm EMT, Yoong C, Robertson TA, Soyer HP, Roberts MS (2011) Nanoparticles and microparticles for skin drug delivery. Adv Drug Deliv Rev 63:470–491
25. Puglia C, Blasi P, Rizza L, Schoubben A, Boninca F, Rossi C, Ricci M (2008) Lipid nanoparticles for prolonged topical delivery: an in vitro and in vivo investigation. Int J Pharm 357:295–304
26. Schneider DJ, Freed JH (1989) Spin labeling. Theory and applications. Berliner LJ, Reuben J (eds), Biological magnetic resonance, plenum, Press, New York
27. Souza LG, Silva EJ, Martins ALL, Mota MF, Braga RC, Lima EM, Valadares MC, Taveira SF, Marreto RN (2011) Development of topotecan loaded lipid nanoparticles for chemical stabilization and prolonged release. Eur J Pharm Biopharm 79:189–196
28. Taveira SF, Nomizo A, Lopez RFV (2009) Effect of the iontophoresis of a chitosan gel on doxorubicin skin penetration and cytotoxicity. J Control Release 134:35–40
29. Taveira SF, Araújo LM, De Santana DC, Nomizo A, De Freitas LA, Lopez RFV (2012) Development of cationic solid lipid nanoparticles with factorial design-based studies for topical administration of doxorubicin. J Biomed Nanotechnol 8:219–228
30. Vitorino C, Almeida A, Sousa J, Lamarche I, Gobin P, Marchand S, Couet W, Oliveri JC, Pais A (2014) Passive and active strategies for transdermal delivery using co-encapsulating nanostructured lipid carriers: in vitro vs. in vivo studies. Eur J Pharm Biopharm 86:133–144
31. Williams AC, Barry BW (2004) Penetration enhancers. Adv Drug Deliv Rev 56:603–618
32. Win KY, Feng SS (2005) Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs. Biomaterials 26:2713–2722
33. Wissing SA, Kayser O, Müller RH (2004) Solid lipid nanoparticles for parenteral drug delivery. Adv Drug Deliv Rev 56:1257–1272
34. Yang Y, Corona A, Schubert B, Reeder R, Henson MA (2014) The effect of oil type on the aggregation stability of nanostructured lipid carriers. J Colloid Interface Sci 418:261–272